サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：特殊ジェネリック注射剤の世界市場規模：タイプ別（医薬品、生物製剤）、用途別（腫瘍、循環器、感染症、中枢神経系、自己免疫疾患、その他）、地域別予測（2022年～2028年）
市場調査レポート
商品コード
1090028

特殊ジェネリック注射剤の世界市場規模：タイプ別（医薬品、生物製剤）、用途別（腫瘍、循環器、感染症、中枢神経系、自己免疫疾患、その他）、地域別予測（2022年～2028年）

Global Specialty Injectable Generics Market Size study, by Type (Drugs, Biologics), by Application (Oncology, Cardiovascular, Infectious Diseases, Central Nervous Systems, Autoimmune Disorders, Others) and Regional Forecasts 2022-2028
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
特殊ジェネリック注射剤の世界市場規模：タイプ別（医薬品、生物製剤）、用途別（腫瘍、循環器、感染症、中枢神経系、自己免疫疾患、その他）、地域別予測（2022年～2028年）
出版日: 2022年06月07日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の特殊ジェネリック注射剤の市場規模は、従来の医薬品に比べて価格が低く、期限切れとなる特許の数が増加していること、新製品の発売、病気の流行が増加傾向にあることなどによって促進されています。

一方で、生物製剤やジェネリック注射剤の製造は高価で困難な作業であり、予測期間における同市場の成長を阻害する可能性があります。

当レポートでは、世界の特殊ジェネリック注射剤市場を調査しており、市場の概要、市場分析、タイプ・用途・地域別の分析、および競合情勢など、包括的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の特殊ジェネリック注射剤市場の定義と範囲

第3章 世界の特殊ジェネリック注射剤市場力学

  • 特殊ジェネリック注射剤市場の影響分析（2020年～2028年）

第4章 世界の特殊ジェネリック注射剤市場：業界分析

  • ポーターのファイブフォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論
  • 主要投資機会
  • 主要成功戦略

第5章 リスク評価：COVID-19の影響

    • 業界に対するCOVID-19の全体的な影響の評価
    • COVID-19以前およびCOVID-19後の市場シナリオ

第6章 世界の特殊ジェネリック注射剤市場：タイプ別

  • 市場スナップショット
  • タイプ別の世界の特殊ジェネリック注射剤市場の実績-潜在性分析
  • タイプ別の世界の特殊ジェネリック注射剤市場の推定と予測（2018年～2028年）
  • 特殊ジェネリック注射剤市場、サブセグメント分析
    • 医薬品
    • 生物製剤

第7章 世界の特殊ジェネリック注射剤市場：用途別

  • 市場スナップショット
  • 用途別の世界の特殊ジェネリック注射剤市場の実績-潜在性分析
  • 用途別の世界の特殊ジェネリック注射剤市場の推定と予測（2018年～2028年）
  • 特殊ジェネリック注射剤市場、サブセグメント分析
    • 腫瘍
    • 循環器
    • 感染症
    • 中枢神経系
    • 自己免疫疾患
    • その他

第8章 世界の特殊ジェネリック注射剤市場：地域別

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカスナップショット
    • ブラジル
    • メキシコ
  • その他の地域

第9章 競合情報

  • 主要市場戦略
  • 企業プロファイル
    • Baxter
    • Cipla Inc.
    • Dr. Reddy's Laboratories Ltd
    • Fresenius Kabi
    • Hikma Pharmaceuticals PLC
    • Novartis AG
    • Par Pharmaceutical
    • Pfizer Inc
    • SAGENT Pharmaceuticals
    • Sun Pharmaceutical Industries Ltd.

第10章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Specialty Injectable Generics Market, report scope
  • TABLE 2. Global Specialty Injectable Generics Market estimates & forecasts by Region 2018-2028 (USD Billion)
  • TABLE 3. Global Specialty Injectable Generics Market estimates & forecasts by Type 2018-2028 (USD Billion)
  • TABLE 4. Global Specialty Injectable Generics Market estimates & forecasts by Application 2018-2028 (USD Billion)
  • TABLE 5. Global Specialty Injectable Generics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 6. Global Specialty Injectable Generics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 7. Global Specialty Injectable Generics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 8. Global Specialty Injectable Generics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 9. Global Specialty Injectable Generics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 10. Global Specialty Injectable Generics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 11. Global Specialty Injectable Generics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 12. Global Specialty Injectable Generics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 13. Global Specialty Injectable Generics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 14. Global Specialty Injectable Generics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 15. U.S. Specialty Injectable Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 16. U.S. Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 17. U.S. Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 18. Canada Specialty Injectable Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 19. Canada Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 20. Canada Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 21. UK Specialty Injectable Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 22. UK Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 23. UK Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 24. Germany Specialty Injectable Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 25. Germany Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 26. Germany Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 27. RoE Specialty Injectable Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 28. RoE Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 29. RoE Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 30. China Specialty Injectable Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 31. China Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 32. China Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 33. India Specialty Injectable Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 34. India Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 35. India Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 36. Japan Specialty Injectable Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 37. Japan Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 38. Japan Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 39. RoAPAC Specialty Injectable Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 40. RoAPAC Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 41. RoAPAC Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 42. Brazil Specialty Injectable Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 43. Brazil Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 44. Brazil Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 45. Mexico Specialty Injectable Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 46. Mexico Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 47. Mexico Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 48. RoLA Specialty Injectable Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 49. RoLA Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 50. RoLA Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 51. Row Specialty Injectable Generics Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 52. Row Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 53. Row Specialty Injectable Generics Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 54. List of secondary sources, used in the study of Global Specialty Injectable Generics Market
  • TABLE 55. List of primary sources, used in the study of Global Specialty Injectable Generics Market
  • TABLE 56. Years considered for the study
  • TABLE 57. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Specialty Injectable Generics Market, research methodology
  • FIG 2. Global Specialty Injectable Generics Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Specialty Injectable Generics Market, key trends 2021
  • FIG 5. Global Specialty Injectable Generics Market, growth prospects 2022-2028
  • FIG 6. Global Specialty Injectable Generics Market, porters 5 force model
  • FIG 7. Global Specialty Injectable Generics Market, pest analysis
  • FIG 8. Global Specialty Injectable Generics Market, value chain analysis
  • FIG 9. Global Specialty Injectable Generics Market by segment, 2018 & 2028 (USD Billion)
  • FIG 10. Global Specialty Injectable Generics Market by segment, 2018 & 2028 (USD Billion)
  • FIG 11. Global Specialty Injectable Generics Market by segment, 2018 & 2028 (USD Billion)
  • FIG 12. Global Specialty Injectable Generics Market by segment, 2018 & 2028 (USD Billion)
  • FIG 13. Global Specialty Injectable Generics Market by segment, 2018 & 2028 (USD Billion)
  • FIG 14. Global Specialty Injectable Generics Market, regional snapshot 2018 & 2028
  • FIG 15. North America Specialty Injectable Generics Market 2018 & 2028 (USD Billion)
  • FIG 16. Europe Specialty Injectable Generics Market 2018 & 2028 (USD Billion)
  • FIG 17. Asia Pacific Specialty Injectable Generics Market 2018 & 2028 (USD Billion)
  • FIG 18. Latin America Specialty Injectable Generics Market 2018 & 2028 (USD Billion)
  • FIG 19. Global Specialty Injectable Generics Market, company Market share analysis (2021)
目次

Global Specialty Injectable Generics Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Specialty Injectable Generics are drug therapies used for the treatment of chronic conditions that need injection, infusion, or inhalation and are sold as generics.. It includes biologics used in the treatment of a variety of drugs and has the same active ingredients as branded versions, although the inactive contents of the medications can vary. Specialty Injectable Generics are less expensive as compared to traditional drugs and growing number of patents set to expire have led to the adoption of Specialty Injectable Generics across the forecast period. For Instance: as per Statista in 2021, the global specialty generics market was valued at roughly 45 billion dollars in 2018, and it is predicted to grow to nearly 90 billion dollars by 2024. Due to patent expiration, the industry is anticipated to lose 19 billion dollars in prescription medicine sales worldwide by 2022. Following the expiration of a patent, other businesses are permitted to produce less expensive generic versions of the original branded drug. Also, as the key market participants are launching new products and illness prevalence is on the rise are likely to increase the market growth during the forecast period. However, manufacturing biologics and generic injectable is an expensive and difficult operation that may impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the Global Specialty Injectable Generics Market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share owing to the growing number of patents set to expire. Whereas, Asia-Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2022-2028. Factors such as key market participants launching new products and rising illness prevalence would create lucrative growth prospects for the Specialty Injectable Generics Market across Asia-Pacific region.

Major Market players included in this report are:

Baxter

Cipla Inc.

Dr. Reddy's Laboratories Ltd

Fresenius Kabi

Hikma Pharmaceuticals PLC

Novartis AG

Par Pharmaceutical

Pfizer Inc

SAGENT Pharmaceuticals

Sun Pharmaceutical Industries Ltd.

The objective of the study is to define Market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the Market. Additionally, the report shall also incorporate available opportunities in micro Markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the Market are explained below:

By Type:

Drugs

Biologics

By Application:

Oncology

Cardiovascular

Infectious Diseases

Central Nervous Systems

Autoimmune Disorders

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Specialty Injectable Generics Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
    • 1.2.1. Specialty Injectable Generics Market, by Region, 2020-2028 (USD Billion)
    • 1.2.2. Specialty Injectable Generics Market, by Type, 2020-2028 (USD Billion)
    • 1.2.3. Specialty Injectable Generics Market, by Application, 2020-2028 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Specialty Injectable Generics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Specialty Injectable Generics Market Dynamics

  • 3.1. Specialty Injectable Generics Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Less expensive as compared to traditional drugs
      • 3.1.1.2. Growing number of patents are set to expire
    • 3.1.2. Market Challenges
      • 3.1.2.1. Manufacturing biologics and generic injectables is an expensive and difficult operation
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Key Market participants are launching new products
      • 3.1.3.2. Illness prevalence is on the rise

Chapter 4. Global Specialty Injectable Generics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Specialty Injectable Generics Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global Specialty Injectable Generics Market by Type, Performance - Potential Analysis
  • 6.3. Global Specialty Injectable Generics Market Estimates & Forecasts by Type, 2018-2028 (USD Billion)
  • 6.4. Specialty Injectable Generics Market, Sub Segment Analysis
    • 6.4.1. Drugs
    • 6.4.2. Biologics

Chapter 7. Global Specialty Injectable Generics Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Specialty Injectable Generics Market by Application, Performance - Potential Analysis
  • 7.3. Global Specialty Injectable Generics Market Estimates & Forecasts by Application, 2018-2028 (USD Billion)
  • 7.4. Specialty Injectable Generics Market, Sub Segment Analysis
    • 7.4.1. Oncology
    • 7.4.2. Cardiovascular
    • 7.4.3. Infectious Diseases
    • 7.4.4. Central Nervous Systems
    • 7.4.5. Autoimmune Disorders
    • 7.4.6. Others

Chapter 8. Global Specialty Injectable Generics Market, Regional Analysis

  • 8.1. Specialty Injectable Generics Market, Regional Market Snapshot
  • 8.2. North America Specialty Injectable Generics Market
    • 8.2.1. U.S. Specialty Injectable Generics Market
      • 8.2.1.1. Type breakdown estimates & forecasts, 2018-2028
      • 8.2.1.2. Application breakdown estimates & forecasts, 2018-2028
    • 8.2.2. Canada Specialty Injectable Generics Market
  • 8.3. Europe Specialty Injectable Generics Market Snapshot
    • 8.3.1. U.K. Specialty Injectable Generics Market
    • 8.3.2. Germany Specialty Injectable Generics Market
    • 8.3.3. France Specialty Injectable Generics Market
    • 8.3.4. Spain Specialty Injectable Generics Market
    • 8.3.5. Italy Specialty Injectable Generics Market
    • 8.3.6. Rest of Europe Specialty Injectable Generics Market
  • 8.4. Asia-Pacific Specialty Injectable Generics Market Snapshot
    • 8.4.1. China Specialty Injectable Generics Market
    • 8.4.2. India Specialty Injectable Generics Market
    • 8.4.3. Japan Specialty Injectable Generics Market
    • 8.4.4. Australia Specialty Injectable Generics Market
    • 8.4.5. South Korea Specialty Injectable Generics Market
    • 8.4.6. Rest of Asia Pacific Specialty Injectable Generics Market
  • 8.5. Latin America Specialty Injectable Generics Market Snapshot
    • 8.5.1. Brazil Specialty Injectable Generics Market
    • 8.5.2. Mexico Specialty Injectable Generics Market
  • 8.6. Rest of The World Specialty Injectable Generics Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Baxter
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Cipla Inc.
    • 9.2.3. Dr. Reddy's Laboratories Ltd
    • 9.2.4. Fresenius Kabi
    • 9.2.5. Hikma Pharmaceuticals PLC
    • 9.2.6. Novartis AG
    • 9.2.7. Par Pharmaceutical
    • 9.2.8. Pfizer Inc
    • 9.2.9. SAGENT Pharmaceuticals
    • 9.2.10. Sun Pharmaceutical Industries Ltd.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption